rs757850760

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBS1BS2

The NM_003924.4(PHOX2B):​c.735_767delGGCGGCCGCGGCAGCGGCGGCGGCGGCAGCGGC​(p.Ala246_Ala256del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00014 in 1,255,482 control chromosomes in the GnomAD database, including 26 homozygotes. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A245A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000082 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00015 ( 26 hom. )

Consequence

PHOX2B
NM_003924.4 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 3.23

Publications

0 publications found
Variant links:
Genes affected
PHOX2B (HGNC:9143): (paired like homeobox 2B) The DNA-associated protein encoded by this gene is a member of the paired family of homeobox proteins localized to the nucleus. The protein functions as a transcription factor involved in the development of several major noradrenergic neuron populations and the determination of neurotransmitter phenotype. The gene product is linked to enhancement of second messenger-mediated activation of the dopamine beta-hydroylase, c-fos promoters and several enhancers, including cyclic amp-response element and serum-response element. Expansion of a 20 amino acid polyalanine tract in this protein by 5-13 aa has been associated with congenital central hypoventilation syndrome. [provided by RefSeq, Jul 2016]
PHOX2B Gene-Disease associations (from GenCC):
  • central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • Haddad syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • neuroblastoma, susceptibility to, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P
  • congenital central hypoventilation syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_003924.4
BP6
Variant 4-41745984-TGCCGCTGCCGCCGCCGCCGCTGCCGCGGCCGCC-T is Benign according to our data. Variant chr4-41745984-TGCCGCTGCCGCCGCCGCCGCTGCCGCGGCCGCC-T is described in ClinVar as Likely_benign. ClinVar VariationId is 467741.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0000819 (12/146574) while in subpopulation SAS AF = 0.00191 (9/4700). AF 95% confidence interval is 0.000999. There are 0 homozygotes in GnomAd4. There are 11 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 12 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PHOX2BNM_003924.4 linkc.735_767delGGCGGCCGCGGCAGCGGCGGCGGCGGCAGCGGC p.Ala246_Ala256del disruptive_inframe_deletion Exon 3 of 3 ENST00000226382.4 NP_003915.2 Q99453

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PHOX2BENST00000226382.4 linkc.735_767delGGCGGCCGCGGCAGCGGCGGCGGCGGCAGCGGC p.Ala246_Ala256del disruptive_inframe_deletion Exon 3 of 3 1 NM_003924.4 ENSP00000226382.2 Q99453
PHOX2BENST00000510424.2 linkn.*16_*48delGGCGGCCGCGGCAGCGGCGGCGGCGGCAGCGGC downstream_gene_variant 3

Frequencies

GnomAD3 genomes
AF:
0.0000819
AC:
12
AN:
146472
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00111
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00191
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000302
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000788
AC:
28
AN:
35526
AF XY:
0.00116
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000606
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000148
AC:
164
AN:
1108908
Hom.:
26
AF XY:
0.000236
AC XY:
126
AN XY:
533988
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
22458
American (AMR)
AF:
0.00
AC:
0
AN:
9086
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
15324
East Asian (EAS)
AF:
0.0000432
AC:
1
AN:
23154
South Asian (SAS)
AF:
0.00511
AC:
134
AN:
26230
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
29280
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3120
European-Non Finnish (NFE)
AF:
0.0000214
AC:
20
AN:
936702
Other (OTH)
AF:
0.000207
AC:
9
AN:
43554
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.671
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000819
AC:
12
AN:
146574
Hom.:
0
Cov.:
32
AF XY:
0.000154
AC XY:
11
AN XY:
71328
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
40776
American (AMR)
AF:
0.00
AC:
0
AN:
14570
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3406
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4628
South Asian (SAS)
AF:
0.00191
AC:
9
AN:
4700
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9170
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
274
European-Non Finnish (NFE)
AF:
0.0000303
AC:
2
AN:
66108
Other (OTH)
AF:
0.00
AC:
0
AN:
2040
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
Jan 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PHOX2B: BS2 -

Haddad syndrome Benign:1
Aug 05, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

PHOX2B-related disorder Benign:1
Jun 05, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
3.2
Mutation Taster
=198/2
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs757850760; hg19: chr4-41748001; API